- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aldeyra Therapeutics Inc (ALDX)
Track today's live Aldeyra (ALDX) share price, performance and key data on this page with our current NASDAQ:ALDX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Aldeyra share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ALDX share price, head to our technical summary section, which provides analysis on Aldeyra share price buy/sell indicators using real-time data (or discuss the Aldeyra (ALDX) stock price today with other investors in the Aldeyra NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ALDX share price (ISIN: US01438T1060) to enhance your trading decisions with our free investment tools and resources.
What Is the Aldeyra Therapeutics Inc Share Price Today?
The Aldeyra share price today is 0.904.
What Is the Stock Symbol for Aldeyra Therapeutics Inc
The stock symbol (or 'ticker') for Aldeyra Therapeutics Inc is "ALDX."
What Stock Exchange Does Aldeyra Therapeutics Inc Trade On?
Aldeyra Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aldeyra Therapeutics Inc a Good Stock to Buy?
Determining whether Aldeyra (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ALDX share price (ISIN: US01438T1060) to enhance your trading decisions with our free investment tools and resources.
What Is the Aldeyra Therapeutics Inc Share Price Today?
The Aldeyra share price today is 0.904.
What Is the Stock Symbol for Aldeyra Therapeutics Inc
The stock symbol (or 'ticker') for Aldeyra Therapeutics Inc is "ALDX."
What Stock Exchange Does Aldeyra Therapeutics Inc Trade On?
Aldeyra Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aldeyra Therapeutics Inc a Good Stock to Buy?
Determining whether Aldeyra (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in USD
0.904
-0.266(-22.77%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.898
1.180
52 wk Range
0.898
5.930
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8981.180
52 wk Range
0.8985.930
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.600
Upside
+630.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Form 4 Aldeyra The For: 11 June- Investing.com
Form 8K Aldeyra Therapeutics Inc For: 29 September- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.600
(+630.09% Upside)
Earnings
Latest Release
31/07/2026
EPS / Forecast
-0.09 / -0.09
Revenue / Forecast
-- / 31.33M
Compare ALDX to Peers and Sector
Metrics to compare | ALDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −1.5x | −0.3x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | 1.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 52.4x | 3.0x | |
Upside (Analyst Target) | - | 277.8% | 58.6% | |
Fair Value Upside | Unlock | 6.7% | 7.4% | Unlock |
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Aldeyra (NASDAQ: ALDX) Share Price Today?
The Aldeyra stock price today is 0.904 USD.
What Stock Exchange Does Aldeyra (ALDX) Trade On?
Aldeyra is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Aldeyra?
The stock symbol (also called a 'ticker') for Aldeyra is "ALDX."
What Is the Current Aldeyra Market Capitalisation?
As of today, Aldeyra (NASDAQ: ALDX) market cap is 58.460M USD.
What Is Aldeyra's (ALDX) Earnings Per Share (TTM)?
The Aldeyra EPS is currently -0.383 (Trailing Twelve Months).
When Is the Next Aldeyra Earnings Date?
Aldeyra's next earnings report will be released on 12/11/2026.
Is ALDX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Aldeyra moving averages and other technical indicators, the daily buy/sell signal for ALDX stock is Strong Sell.
How Many Times Has Aldeyra Stock Split?
Aldeyra has split 0 times. (See the ALDX stock split history page for full effective split date and price information.)
How Many Employees Does Aldeyra Have?
Aldeyra has 6 employees, based on their latest Companies House report.
What is the current trading status of Aldeyra (NASDAQ: ALDX)?
As of 05/10/2026, Aldeyra (ALDX) is trading at a share price of 0.904 USD, with a previous close of 1.170 USD. The stock has fluctuated within a day range of 0.898 USD to 1.180 USD, while its 52-week range spans from 0.898 USD to 5.930 USD.
What Is Aldeyra (ALDX) Price Target According to Analysts?
The average 12-month price target for Aldeyra is 6.600 USD, with a high estimate of 13 USD and a low estimate of 2 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +630.09% Upside potential.
What Is the ALDX Premarket Price?
ALDX's last pre-market stock price is 1.188 USD. The pre-market share volume is 12,590.000, and the stock has decreased by 0.018, or 1.540%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.